COVID-19

COVID-19: Current knowledge on prevention of complications 

As we learn about life with COVID-19, the scientific community is working to develop better solutions. The development of treatments has improved the prevention of complications that can lead to hospitalization. Join Marc Geirnaert, Director of the Provincial Oncology Drug Program at CancerCare Manitoba, as he discusses the latest protective treatments available in Canada to prevent hospitalizations. 

Virtual Event

Virtual Event

Agenda

14:00 - 14:50
COVID-19: Current knowledge on prevention of complications 
14:50 - 15:00
Q&A

Speaker

Marc Geirnaert
Marc Geirnaert
Director, Provincial Oncology Drug Program, CancerCare Manitoba Pharmacy 
Marc Geirnaert is the Director of the Provincial Oncology Drug Program at CancerCare Manitoba. His area of interests include the implementation of new treatments for solid tumour and hematological cancers and implementation of biosimilars. 

This event was made possible thanks to the support of: